TickerFactsScreenerDevelopers

VYNE Therapeutics Inc. (VYNE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2014: -$11.41M2015: -$15.95M2016: -$29.44M2017: $68.60M2018: $92.18M2019: $17.57M2020: $37.49M2021: $48.64M2022: $31.20M2023: $88.73M2024: $52.09M2025: $27.77M$27.77M
2014Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$27.77M-46.7%
2024$52.09M-41.3%
2023$88.73M+184.4%
2022$31.20M-35.8%
2021$48.64M+29.7%
2020$37.49M+113.3%
2019$17.57M-80.9%
2018$92.18M+34.4%
2017$68.60M+333.0%
2016-$29.44M-84.5%
2015-$15.95M-39.8%
2014-$11.41M—